The ADC binds TROP2 on tumor cells, is internalized, and releases a topoisomerase I inhibitor that causes DNA damage and apoptosis; DNA topoisomerase I is the intracellular enzyme inhibited by the payload, not the antigen used for targeting, so cells are not killed specifically for expressing topoisomerase I (though bystander killing may occur).